Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
18.74
+0.21 (1.13%)
At close: Jun 18, 2026, 4:00 PM EDT
18.73
-0.01 (-0.08%)
After-hours: Jun 18, 2026, 5:39 PM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $2.12 billion as of June 18, 2026. Its market cap has increased by 170.41% in one year.
Market Cap
2.12B
Enterprise Value
1.50B
1-Year Change
170.41%
Ranking
Category
Stock Price
$18.74
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.12B, an increase of 1,805.28%. That is a compound annual growth rate of 67.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.12B | -10.45% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 2.13B |
| Intellia Therapeutics | 2.08B |
| Trevi Therapeutics | 2.08B |
| Nektar Therapeutics | 2.07B |
| Aurinia Pharmaceuticals | 2.06B |
| Zai Lab | 1.99B |
| Harmony Biosciences Holdings | 1.98B |
| Mineralys Therapeutics | 1.97B |